| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 817 | 0 | 483 | 5.416 | 13.389 | 27.429 | 27.152 |
| Total Income - EUR | - | - | - | 817 | 0 | 483 | 5.416 | 13.389 | 30.664 | 27.152 |
| Total Expenses - EUR | - | - | - | 14 | 43 | 28 | 242 | 1.141 | 5.887 | 15.642 |
| Gross Profit/Loss - EUR | - | - | - | 803 | -43 | 455 | 5.174 | 12.248 | 24.777 | 11.510 |
| Net Profit/Loss - EUR | - | - | - | 778 | -43 | 439 | 5.031 | 11.850 | 20.645 | 9.135 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Twentyarb Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 26 | 0 | 0 | 0 | 1.952 | 42.049 | 30.407 |
| Current Assets | - | - | - | 834 | 46 | 470 | 5.702 | 11.515 | 7.751 | 3.812 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 8 | 8 |
| Cash | - | - | - | 834 | 46 | 470 | 5.702 | 11.515 | 7.743 | 3.804 |
| Shareholders Funds | - | - | - | 821 | 7 | 446 | 5.467 | 12.104 | 21.066 | 16.972 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 39 | 38 | 24 | 235 | 1.363 | 29.572 | 17.815 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Twentyarb Med S.r.l.